enGene Therapeutics Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
enGene Therapeutics Inc. (ENGN) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$103.73 million for the 12-month period ending 2025-10-31, per its 10-K filed 2025-12-22.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2025-12-22
- enGene Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$103.73M.
- enGene Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$53.46M.
- enGene Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$99.16M.
- enGene Therapeutics Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$23.96M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-10-31 | -$103.73M 10-K · filed 2025-12-22 |
| 2024-10-31 | -$53.46M 10-K · filed 2025-12-22 |
| 2023-10-31 | -$99.16M 10-K · filed 2024-12-19 |
| 2022-10-31 | -$23.96M 10-K · filed 2024-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |